More about

T-Cell Lymphoblastic Lymphoma

News
December 12, 2022
3 min read
Save

Experimental CAR-T safe, ‘highly effective’ for certain patients with T-cell malignancies

NEW ORLEANS — A novel chimeric antigen receptor T-cell therapy conferred a 78% complete response rate in patients with heavily pretreated T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, study results showed.

News
June 14, 2022
2 min read
Save

Bortezomib extends survival of children with newly diagnosed T-cell lymphoblastic lymphoma

The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell lymphoblastic lymphoma, according to phase 3 study results published in Journal of Clinical Oncology.